Lumen Bioscience
Latest round
- Series C
Last raised
- Oct 2025
Total raised
- $57M
Investors
- 5
About Lumen Bioscience
Lumen Bioscience, Inc.Founded in 2017, Lumen Bioscience, Inc. is based in Seattle, US. The company focuses on creating next-generation biologic treatments and has successfully completed 4 deals.00 mn.Lumen Bioscience primarily focuses on developing next-generation biologic drugs using its patented technology that leverages the food algae spirulina for delivering therapeutic proteins. Their core product offerings include LMN-801, an oral therapeutic aimed at weight loss that uniquely avoids the muscle-wasting side effects commonly associated with GLP-1 drugs, and LMN-201, an oral capsule designed to treat C. difficile infections. These products aim to provide greater patient convenience and efficacy compared to existing treatments, targeting significant unmet medical needs in various therapeutic areas, including metabolic disease and gastrointestinal infections.Lumen Bioscience's revenue model is primarily structured around partnerships and collaborations, focusing on strategic alliances to facilitate the development and distribution of its biologic products. Transactions typically involve agreements with healthcare providers and pharmaceutical companies, allowing for the distribution of their flagship products, LMN-801 and LMN-201, directly to end-users in clinical settings. The company's offerings cater to both B2B and direct-to-consumer markets, enhancing accessibility for patients suffering from conditions such as obesity and C. difficile infections. The company is targeting expansion into Europe and Asia by 2025, aiming to address the growing demand for effective treatments in these regions. In October 2025, Lumen Bioscience, Inc.
Who invested in Lumen Bioscience
5 investors across 3 rounds
See all investors in Lumen Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lumen Bioscience
Who invested in Lumen Bioscience?
Lumen Bioscience has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lumen Bioscience raised?
Lumen Bioscience has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Lumen Bioscience last raise money?
Lumen Bioscience's most recent round on record is a Series C, in Oct 2025.
What does Lumen Bioscience do?
Lumen Bioscience is a biotechnology company.
Where is Lumen Bioscience headquartered?
Lumen Bioscience is headquartered in Seattle, US.
Which VCs invest in companies like Lumen Bioscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lumen Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Lumen Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.